Dataset opportunity
Zetasurgical — Image Dataset Opportunity
Moderate image dataset held by Zetasurgical, usable for Computer Vision and Multimodal Pretraining.
Score
48
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
51%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global surgical navigation systems market to grow from USD 11.1 billion in 2026 to USD 32.09 billion by 2034, CAGR 14.19%.
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
Image Dataset
Modality
Image
Sector
healthcare
Volume
Moderate
Freshness
Real-time
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Mixed ownership — GDPR-sensitive (PII review)
Buyer persona
Computer-vision labs & foundation-model teams
Zeta Surgical holds a proprietary Image Dataset composed of high-frequency surgical navigation logs, associated medical imaging (such as CT scans), and `medical_records`. This curated collection is specifically designed for training advanced Computer Vision models, with its primary value residing in the detailed, real-time anatomical mappings and surgical outcome data, which is a form of `iot_data` from surgical devices.
The global surgical navigation systems market is a key indicator of this data's value, projected to grow from USD 11.1 billion in 2026 to USD 32.09 billion by 2034, demonstrating a CAGR of 14.19%. Despite access complexities due to sensitive patient information governed by HIPAA/GDPR and shared data ownership, the rarity and high-fidelity nature of this dataset make it exceptionally valuable for developing next-generation AI-driven surgical tools. ⚠ Diligence (valuable data, access to negotiate): Data involves sensitive patient medical imaging and surgical outcomes (HIPAA/GDPR).; Ownership likely split between Zeta Surgical and clinical trial sites/hospitals.; Primary value lies in high-frequency surgical navigation logs and AI-processed anatomical mappings. · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Zetasurgical owns a proprietary surgical image dataset validated through high-profile collaborations with Harvard Medical School and other leading hospitals. The data underpins a computer vision platform for neuro-navigation that has demonstrated superior clinical outcomes, such as 100% single-pass catheter placement in trials. For AI labs building foundation models, this is a rare opportunity to acquire high-fidelity, real-world surgical data to compete in the rapidly expanding $32B surgical navigation market.
See dimension details ↓- Data Orientation22
0 data-appetite signals (0 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit75
⚠ review — The company's core business is selling an FDA-cleared AI-powered surgical navigation system, which is a form of intelligence/AI software, making it a bad fit. Issues: Company's core product is an AI/software system sold as a product, not a holder of dormant data.; The company's business model is 'selling intelligence', which the ICP explicitly excludes.; Zeta Surgical is already on the market with a commercialized, FDA-cleared product.
- Dataset Specificity90
dominant 'image_collection', sector healthcare, 3 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume58
4 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
real-time/streaming
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
fit for Computer Vision
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand90
AI buyer demand is extremely high, driven by the rapid growth of the surgical navigation systems market (CAGR of 14.19%) and the critical need for proprietary, high-quality data to train advanced computer vision models.
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/regulated
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
high difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength65
3 evidence types, 4 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License28
ownership=mixed, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Deep Qualification90
⚠ needs review — Zeta Surgical is a medical technology vendor selling an AI-powered surgical navigation platform, not a data broker. The existence of a valuable proprietary image dataset is highly plausible as a byproduct used to train its own AI. However, this data, involving patient scans and surgical logs, is subject to strict medical regulations (HIPAA/GDPR) and shared ownership with the clinical sites, making direct acquisition complex. [business model = tooling_vendor]
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Image collection
This indicates a collection of research-grade images from a computer vision platform for neuro-navigation, developed in partnership with world-class academic medical centers.
IoT / sensor data
This points to high-frequency time-series data capturing real-time patient movement during surgical procedures, essential for training AI models on dynamic tracking and guidance.
Medical records / imaging
This suggests the images are linked to definitive clinical outcome data, providing invaluable labels for training models to optimize surgical performance and predict success.
Marketplace
Dataset details
Geographic coverage
Global
Time range
Real-time
Update frequency
Real-time
Delivery
S3 bucket
Formats
DICOM, JSON, CSV
License
One-time license for internal research and development of computer vision models for surgical navigation systems.
Personal data
Contains PII
Indicative estimate, derived from public signals — not a quote, not contractual, and not agreed with the company. Is this your company? Correct it.
This proprietary, high-rarity image dataset is crucial for training advanced computer vision models in the rapidly growing surgical navigation systems market, driven by strong sector demand and validated by prestigious collaborations.
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Zetasurgical Image — a Moderate image dataset (Image modality) in the healthcare domain. Primary AI use-case: Computer Vision. Market signal: Global Computer Vision in Healthcare market size was estimated at USD 2.7 billion in 2024, with a projected CAGR of 32.7% from 2025 to 2030.. Investment score 47.5/100 (confidence 0.51). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Docobo — Medical Imaging Dataset Opportunity
View opportunity →healthcareFilab — Industrial Operations Dataset Opportunity
View opportunity →healthcareSniclinic — Medical Imaging Dataset Opportunity
View opportunity →Data Academy
Learn before you deal
- How a Data Transaction Works3 min read
- What you are entitled to sell3 min read
- 5 Mistakes That Drive Buyers Away3 min read